ArticleAnnals of hematology2024

Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.

Salvatore Leotta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.